Next Generation Sequencing Market Trend in 2025 – TOP Vendors PerkinElmer, Oxford Nanopore Technologies, Eurofins Scientific, Thermo Fisher Scientific, Beijing Genomics Institute, Agilent Technologies, Qiagen N.V., Macrogen and Illumina

Next Generation Sequencing Market is estimated to grow at a CAGR of 21.1% during the forecast period from 2018 to 2025. The next generation sequencing market is estimated to reach US$ 26,501.25 Mn by 2025.

The global next generation sequencing market is a matured market in the developing countries as well as developing economies worldwide. The necessity of genetic analysis is constantly increasing in recent days due to the reliable and accurate results being offered by the technique. The demand for next generation sequencing is experienced mostly from academic institutions followed by hospitals & clinics. Among the applications, the demand for next generation sequencing is significantly high in diagnostics, drug discovery, followed by precision medicine.

Furthermore, advancements in sequencing technologies and declining cost of sequencing is expected to be a driving factor for the next generation market.

Get PDF Sample Copy of this Report @ http://bit.ly/2Tp99py

Top Dominating Key Players:

1. Illumina, Inc.
2. Thermo Fisher Scientific, Inc.
3. Qiagen N.V.
4. Beijing Genomics Institute
5. Perkinelmer, Inc.
6. F. Hoffmann-La Roche AG
7. Agilent Technologies
8. Eurofins Scientific
9. Oxford Nanopore Technologies, Ltd.
10. Macrogen, Inc.

Modification and automation of this process continued to increase sequencing data and time reduction. Thereby allowing researchers to reach major milestones in the Human Genome Project. NGS makes sequence based gene expression analysis a "digital? alternative to analog techniques. It also aids in quantifying RNA expression with the breadth of a microarray and the resolution of qPCR. Advancement in genome sequencing has made the sequencing easy and accurate. These technological advancement are likely to grow the market in near future.

Cancer can be cured if diagnosed and treated at an initial stage. Cancer sequencing using next-generation sequencing (NGS) methods provides more information. Additionally, NGS also aids in diagnostics and treatment of cancer. In recent years, the cases of cancer has been increasing tremendously and the trend is anticipated to remain the same in the upcoming years. Due to preference of better technologies for detection of fatal disease, the demand for next generation sequencing is anticipated to witness constant growth in the upcoming years.

The market for next generation sequencing is well established in the region of North America, owing to the awareness regarding medical practices and technological developments in the process of next generation technology. Various market players have been focusing towards shifting their customer base in North America. For instance, Illumina, Inc. along with Telegraph, established a company called Verogen. The company would be entitled to provide Illumina's forensic products to the customers in the US.

The report segments the global next generation sequencing market as follows:

Global Next Generation Sequencing Market - By Product

• Platforms

o Hiseq Series
o Miseq Series
o Solid
o ION Torrent
o Pacbio Rs II & Sequel Systems
o Other Platforms

• Services

o Sequencing Services
o RNA sequencing services
o Whole Genome Sequencing Services
o Whole Exome Sequencing Services
o Targeted Sequencing Services
o Chip Sequencing Services
o Other Sequencing Services

• Data Management & Analysis Services Market

o NGS Data Analysis Market
o NGS Data Analysis Software & Workbenches
o Other Data Management & Analysis Services

Global Next Generation Sequencing Market - By Technology

• Genome Sequencing
• Exome Sequencing
• Resequencing & Targeted Sequencing Oil & Gas
• DNA-based Resequencing & Targeted Sequencing
• RNA-based Resequencing & Targeted Sequencing
• Other Sequencing Technologies

Global Next Generation Sequencing Market - By Application

• Diagnostics
• Drug Discovery
• Precision Medicine
• Others

Global Next Generation Sequencing Market - By End-User

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinics
• Other End Users

Request for Discount @ http://bit.ly/2Ta17BB

Reason to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Global Next Generation Sequencing Market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Next Generation Sequencing, thereby allowing players to develop effective long term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: www.theinsightpartners.com

This release was published on openPR.